These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32275382)

  • 1. A Photoswitchable Inhibitor of the Human Serotonin Transporter.
    Cheng B; Morstein J; Ladefoged LK; Maesen JB; Schiøtt B; Sinning S; Trauner D
    ACS Chem Neurosci; 2020 May; 11(9):1231-1237. PubMed ID: 32275382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
    Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
    Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons.
    Lau T; Horschitz S; Berger S; Bartsch D; Schloss P
    FASEB J; 2008 Jun; 22(6):1702-14. PubMed ID: 18216289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanism for the Allosteric Inhibition of the Human Serotonin Transporter by Antidepressant Escitalopram.
    Xue W; Fu T; Deng S; Yang F; Yang J; Zhu F
    ACS Chem Neurosci; 2022 Feb; 13(3):340-351. PubMed ID: 35041375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.
    Plenge P; Abramyan AM; Sørensen G; Mørk A; Weikop P; Gether U; Bang-Andersen B; Shi L; Loland CJ
    Nat Commun; 2020 Mar; 11(1):1491. PubMed ID: 32198394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
    Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
    J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.
    Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K
    ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound.
    Zhang L; Rasenick MM
    J Pharmacol Exp Ther; 2010 Mar; 332(3):977-84. PubMed ID: 19996298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism in the human serotonin transporter introduces a new site for N-linked glycosylation.
    Rasmussen TN; Plenge P; Bay T; Egebjerg J; Gether U
    Neuropharmacology; 2009 Sep; 57(3):287-94. PubMed ID: 19500602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain.
    Gradisch R; Szöllősi D; Niello M; Lazzarin E; Sitte HH; Stockner T
    J Biol Chem; 2022 Mar; 298(3):101613. PubMed ID: 35065961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.
    Mortensen OV; Kristensen AS; Wiborg O
    J Neurochem; 2001 Oct; 79(2):237-47. PubMed ID: 11677251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.
    Horschitz S; Hummerich R; Schloss P
    Neuroreport; 2001 Jul; 12(10):2181-4. PubMed ID: 11447330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.